Tarsus Pharmaceuticals (TARS)

• Market cap: $3.08B
• 1 day: -2.72%
• 5 days: 4.19%
• 1 month: 41.09%
• 3 months: 76.16%
• 6 months: 48.08%
• Year to date: 32.24%
• 1 year: 96.74%
• 5 years: 231.5%
• 10 years: 254.37%
• Sector: Healthcare
• Industry: Biotechnology

About: Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Employees: 323